Historic Milestone in Medical Science: Brookhaven’s Medical Research Reactor Achieves Criticality in 1959

On March 15, 1959, a significant breakthrough in nuclear medicine occurred when the Brookhaven Medical Research Reactor successfully reached criticality for the first time. Built at Brookhaven National Laboratory in the United States, the reactor was designed specifically for medical and scientific research rather than electricity generation.

Unlike conventional nuclear power reactors, the Brookhaven Medical Research Reactor operated at a modest output of about three megawatts thermal. This made it considerably smaller than the reactors used for power production, allowing scientists to focus on controlled experiments and medical applications of nuclear technology.

The primary purpose of the reactor was to support research into an innovative cancer treatment method known as Boron Neutron Capture Therapy. This technique involves delivering boron-containing compounds directly into cancerous tumors. Once these compounds accumulate inside the tumor cells, the area is exposed to neutron radiation from the reactor. The interaction between boron atoms and neutrons produces high-energy particles that destroy cancer cells while minimizing damage to surrounding healthy tissue.

Researchers believed this targeted approach could be particularly useful in treating aggressive brain cancers such as Glioblastoma Multiforme, a fast-growing and often difficult-to-treat form of brain tumor. The reactor allowed scientists to study how neutron radiation could interact with boron-based drugs to improve cancer therapy outcomes.

For decades, the facility supported a wide range of experiments in nuclear medicine, radiobiology, and cancer treatment research. It also helped advance scientific understanding of how neutron radiation interacts with biological tissues, laying the groundwork for further developments in targeted radiation therapies.

After more than four decades of contributing to medical research, the Brookhaven Medical Research Reactor was permanently shut down in December 2000. By that time, advances in technology and the development of alternative research facilities had reduced the need for the reactor.

Despite its closure, the legacy of the Brookhaven Medical Research Reactor remains significant. It played a pioneering role in exploring how nuclear science could be applied to medicine, helping scientists develop innovative approaches to cancer treatment that continue to influence research today.